title: Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels.
abstract: The objective of this study was to assess the frequency of blood-brain barrier (BBB) impairment, as measured by the albumin ratio, in neuro-asymptomatic HIV-1-infected individuals without antiretroviral treatment and the correlation between BBB disruption and intrathecal immune activation and HIV-1 RNA levels. Serum and cerebrospinal fluid (CSF) albumin, neopterin, and HIV-1 RNA levels were analysed in 110 neuro-asymptomatic HIV-1-infected individuals at different stages of disease; 63 classified as CDC A, 25 as CDC B, and 22 as CDC C. Increased BBB permeability was found in 17 of 110 (15%) of HIV-1-infected individuals. This proportion was sustained throughout the CDC stages. The albumin ratio was correlated with the CSF neopterin levels (r(s) = 0.36, P < 0.001), the serum neopterin levels (r(s) = 0.37, P < 0.001), and the CSF HIV-1 RNA levels (r(s) = 0.26, P < 0.01), but not with the plasma HIV-1 RNA levels. The correlations between the albumin ratio and the CSF and serum neopterin concentrations and the CSF HIV-1 RNA levels indicate that immune activation and, possibly, intrathecal HIV-1 virus replication are important factors associated with increased BBB permeability in HIV-1 infection.
authors.affiliation: Institute of Internal Medicine, Department of Infectious Diseases, Sahlgrenska University Hospital, S-416 85 Göteborg, Sweden. lars-magnus.andersson@medfak.gu.se
authors.forename: L M
authors.initials: LM
authors.lastname: Andersson
authors.forename: L
authors.initials: L
authors.lastname: Hagberg
authors.forename: D
authors.initials: D
authors.lastname: Fuchs
authors.forename: B
authors.initials: B
authors.lastname: Svennerholm
authors.forename: M
authors.initials: M
authors.lastname: Gisslén
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D019380:Anti-HIV Agents / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D005260:Female; D015658:HIV Infections / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000503:physiopathology*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019798:Neopterin / Q000097:blood / Q000134:cerebrospinal fluid*; D012367:RNA, Viral / Q000097:blood / Q000134:cerebrospinal fluid; D012709:Serum Albumin / Q000134:cerebrospinal fluid
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral; D012709:Serum Albumin; D019798:Neopterin